Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer. Watanabe T, Oba T, Tanimoto K, Shibata T, et al. PLoS One 2021;16:e0252822.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watanabe T, Oba T, Tanimoto K, Shibata T, et al. Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer. PLoS One 2021;16:e0252822.
PMID: 34101751